Charles River Laboratories International (CRL) Total Liabilities (2009 - 2025)

Charles River Laboratories International's Total Liabilities history runs 17 years deep, the most recent figure standing at $3.9 billion for Q4 2025.

• In Q4 2025, Total Liabilities fell 2.39% year-over-year to $3.9 billion; the TTM figure through Dec 2025 stood at $3.9 billion (down 2.39% YoY), while the FY2025 annual figure was $3.9 billion, down 2.39% from the prior year.
• Total Liabilities was $3.9 billion for Q4 2025 at Charles River Laboratories International, down from $4.1 billion in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $4.8 billion in Q2 2022 to a low of $3.6 billion in Q1 2021.
• Historically, Total Liabilities has averaged $4.3 billion across 5 years, with a median of $4.4 billion in 2021.
• The sharpest annual moves came in 2021 and 2024: Total Liabilities soared 341.59% in 2021, then decreased 11.37% in 2024.
• A 5-year view of Total Liabilities shows it stood at $4.4 billion in 2021, then gained by 3.32% to $4.6 billion in 2022, then fell by 0.94% to $4.5 billion in 2023, then retreated by 11.37% to $4.0 billion in 2024, then dropped by 2.39% to $3.9 billion in 2025.
• The last three Total Liabilities figures came in at $3.9 billion (Q4 2025), $4.1 billion (Q3 2025), and $4.2 billion (Q2 2025), per Business Quant data.